TGF-beta signaling in cartilage homeostasis and osteoarthritis

Frontiers in Bioscience - Scholar

Volumn 4 S, Issue 1, 2012, Pages 251-268

  Finnson, Kenneth W ^a   Chi, Yoon ^a   Bou Gharios, George ^c   Leask, Andrew ^b   Philip, Anie ^a  

^a MONTREAL GENERAL HOSPITAL   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Betaglycan; Cartilage; CD109; Chondrocyte; Endoglin; Osteoarthritis; TGF ; TGF co receptors

Indexed keywords

CADMIUM 109; ENDOGLIN; SMAD1 PROTEIN; SMAD2 PROTEIN; SMAD3 PROTEIN; SMAD5 PROTEIN; SMAD7 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 3;

ARTICLE; ARTICULAR CARTILAGE; CARTILAGE; CARTILAGE CELL; CARTILAGE DEGENERATION; CATABOLISM; CELL SURFACE; EXTRACELLULAR MATRIX; FIBROSIS; HOMEOSTASIS; HUMAN; NONHUMAN; OSTEOARTHRITIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; ANIMAL; JOINT; METABOLISM; PATHOLOGY; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; CARTILAGE; CARTILAGE, ARTICULAR; CHONDROCYTES; HOMEOSTASIS; HUMANS; JOINTS; OSTEOARTHRITIS; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 84867839701     PISSN: 19450516     EISSN: 19450524     Source Type: Journal    
DOI: 10.2741/266     Document Type: Article

References (193)

1. E. Blaney Davidson, P. van der Kraan and W. van den Berg: TGF-β and osteoarthritis. Osteoarthritis Cartilage, 15(6), 597-604 (2007)
2. B. Song, K. D. Estrada and K. M. Lyons: Smad signaling in skeletal development and regeneration. Cytokine Growth Factor Rev, 20(5-6), 379-88 (2009)
3. P. M. van der Kraan, E. N. Blaney Davidson, A. Blom and W. B. van den Berg: TGF-β signaling in chondrocyte terminal differentiation and osteoarthritis: modulation and integration of signaling pathways through receptor-Smads. Osteoarthritis Cartilage, 17(12), 1539-45 (2009)
4. S. J. Chang, C. J. Chen, F. C. Tsai, H. M. Lai, P. C. Tsai, M. H. Tsai and Y. C. Ko: Associations between gout tophus and polymorphisms 869T/C and -509C/T in transforming growth factor β1 gene. Rheumatology (Oxford), 47(5), 617-21 (2008)
5. N. Dalbeth, B. Pool, G. D. Gamble, T. Smith, K. E. Callon, F. M. McQueen and J. Cornish: Cellular characterization of the gouty tophus: a quantitative analysis. Arthritis Rheum, 62(5), 1549-56 (2010)
6. M. A. Kriegel, M. O. Li, S. Sanjabi, Y. Y. Wan and R. A. Flavell: Transforming growth factor-β: recent advances on its role in immune tolerance. Curr Rheumatol Rep, 8(2), 138-44 (2006)
7. E. Y. Kim and K. D. Moudgil: Regulation of autoimmune inflammation by pro-inflammatory cytokines. Immunol Lett, 120(1-2), 1-5 (2008)
8. D. Pohlers, J. Brenmoehl, I. Loffler, C. K. Muller, C. Leipner, S. Schultze-Mosgau, A. Stallmach, R. W. Kinne and G. Wolf: TGF-β and fibrosis in different organs - molecular pathway imprints. Biochim Biophys Acta, 1792(8), 746-56 (2009)
9. P. M. van der Kraan, E. N. Blaney Davidson and W. B. van den Berg: A role for age-related changes in TGF-β signaling in aberrant chondrocyte differentiation and osteoarthritis. Arthritis Res Ther, 12(1), 201 (2010)
10. C. J. Malemud: Anticytokine therapy for osteoarthritis: evidence to date. Drugs Aging, 27(2), 95-115 (2010)
11. M. Y. Wu and C. S. Hill: TGF-β superfamily signaling in embryonic development and homeostasis. Dev Cell, 16(3), 329-43 (2009)
12. K. Wharton and R. Derynck: TGF-β family signaling: novel insights in development and disease. Development, 136(22), 3691-7 (2009)
13. A. Moustakas and C. H. Heldin: The regulation of TGFβ signal transduction. Development, 136(22), 3699- 714 (2009)
14. C. Heldin, M. Landstrom and A. Moustakas: Mechanism of TGF-β signaling to growth arrest, apoptosis, and epithelial-mesenchymal transition. Current Opinion in Cell Biology, 21(2), 166-176 (2009)
15. M. P. Schlunegger and M. G. Grutter: An unusual feature revealed by the crystal structure at 2.2 A resolution of human transforming growth factor-β2. Nature, 358(6385), 430-4 (1992)
16. P. R. Mittl, J. P. Priestle, D. A. Cox, G. McMaster, N. Cerletti and M. G. Grutter: The crystal structure of TGF-β3 and comparison to TGF-β2: implications for receptor binding. Protein Sci, 5(7), 1261-71 (1996)
17. A. P. Hinck, S. J. Archer, S. W. Qian, A. B. Roberts, M. B. Sporn, J. A. Weatherbee, M. L. Tsang, R. Lucas, B. L. Zhang, J. Wenker and D. A. Torchia: Transforming growth factor β1: three-dimensional structure in solution and comparison with the X-ray structure of transforming growth factor β2. Biochemistry, 35(26), 8517-34 (1996)
18. S. Daopin, K. A. Piez, Y. Ogawa and D. R. Davies: Crystal structure of transforming growth factor-β2: an unusual fold for the superfamily. Science, 257(5068), 369- 73 (1992)
19. S. Radaev, Z. Zou, T. Huang, E. M. Lafer, A. P. Hinck and P. D. Sun: Ternary complex of TGF-β1 reveals isoform-specific ligand recognition and receptor recruitment in the superfamily. J Biol Chem, 285(19), 14806-14 (2010)
20. E. P. Bottinger, J. J. Letterio and A. B. Roberts: Biology of TGF-β in knockout and transgenic mouse models. Kidney Int, 51(5), 1355-60 (1997)
21. A. B. Roberts and M. B. Sporn: Differential expression of the TGF-β isoforms in embryogenesis suggests specific roles in developing and adult tissues. Mol Reprod Dev, 32(2), 91-8 (1992)
22. F. Ramirez and D. B. Rifkin: Extracellular microfibrils: contextual platforms for TGFβ and BMP signaling. Curr Opin Cell Biol, 21(5), 612-622 (2009)
23. R. O. Hynes: The extracellular matrix: not just pretty fibrils. Science, 326(5957), 1216-9 (2009)
24. G. Jenkins: The role of proteases in transforming growth factor-β activation. Int J Biochem Cell Biol, 40(6- 7), 1068-1078 (2008)
25. J. P. Annes, J. S. Munger and D. B. Rifkin: Making sense of latent TGF-β activation. Journal of Cell Science, 116(2), 217-224 (2003)
26. P. J. Wipff and B. Hinz: Integrins and the activation of latent transforming growth factor β1 - An intimate relationship. Eur J Cell Biol (2008)
27. J. E. Murphy-Ullrich and M. Poczatek: Activation of latent TGF-β by thrombospondin-1: mechanisms and physiology. Cytokine Growth Factor Rev, 11(1-2), 59- 69 (2000)
28. S. L. Nishimura: Integrin-mediated transforming growth factor-β activation, a potential therapeutic target in fibrogenic disorders. Am J Pathol (2009)
29. P. Aluwihare and J. S. Munger: What the lung has taught us about latent TGF-β activation. Am J Respir Cell Mol Biol, 39(5), 499-502 (2008)
30. J. D. Thatcher: The TGF-β signal transduction pathway. Sci Signal, 3(119), tr4 (2010)
31. J. Massague and R. R. Gomis: The logic of TGF-β signaling. FEBS Lett, 580(12), 2811-20 (2006)
32. Y. Shi and J. Massague: Mechanisms of TGF-β signaling from cell membrane to the nucleus. Cell, 113(6), 685-700 (2003)
33. B. Schmierer and C. S. Hill: TGFβ-Smad signal transduction: molecular specificity and functional flexibility. Nat Rev Mol Cell Biol (2007)
34. S. Ross and C. S. Hill: How the Smads regulate transcription. Int J Biochem Cell Biol, 40(3), 383-408 (2008)
35. M. Goumans, G. Valdimarsdottir, S. Itoh, A. Rosendahl, P. Sideras and P. ten Dijke: Balancing the activation state of the endothelium via two distinct TGF- β type I receptors. Embo J, 21(7), 1743-53 (2002)
36. M. J. Goumans, G. Valdimarsdottir, S. Itoh, F. Lebrin, J. Larsson, C. Mummery, S. Karlsson and P. ten Dijke: Activin receptor-like kinase (ALK)1 is an antagonistic mediator of lateral TGF-β/ALK5 signaling. Mol Cell, 12(4), 817-28 (2003)
37. K. W. Finnson, W. L. Parker, P. ten Dijke, M. Thorikay and A. Philip: ALK1 opposes ALK5/Smad3 signaling and expression of extracellular matrix components in human chondrocytes. J Bone Miner Res, 23(6), 896-906 (2008)
38. Y. E. Zhang: Non-Smad pathways in TGF-β signaling. Cell Res, 19, 128-139 (2008)
39. A. Moustakas and C. H. Heldin: Non-Smad TGF-β signals. J Cell Sci, 118(Pt 16), 3573-84 (2005)
40. R. Derynck and Y. E. Zhang: Smad-dependent and Smad-independent pathways in TGF-β family signalling. Nature, 425(6958), 577-84 (2003)
41. M. E. Dockrell, M. K. Phanish and B. M. Hendry: TGF-β auto-induction and connective tissue growth factor expression in human renal tubule epithelial cells requires N-ras. Nephron Exp Nephrol, 112(3), e71-9 (2009)
42. H. Nishi, T. Nakada, M. Hokamura, Y. Osakabe, O. Itokazu, L. E. Huang and K. Isaka: Hypoxia-inducible factor-1 transactivates transforming growth factor-β3 in trophoblast. Endocrinology, 145(9), 4113-8 (2004)
43. H. Zhang, H. O. Akman, E. L. Smith, J. Zhao, J. E. Murphy-Ullrich and O. A. Batuman: Cellular response to hypoxia involves signaling via Smad proteins. Blood, 101(6), 2253-60 (2003)
44. L. Schaffer, A. Scheid, P. Spielmann, C. Breymann, R. Zimmermann, M. Meuli, M. Gassmann, H. H. Marti and R. H. Wenger: Oxygen-regulated expression of TGF-β3, a growth factor involved in trophoblast differentiation. Placenta, 24(10), 941-50 (2003)
45. A. Scheid, R. H. Wenger, L. Schaffer, I. Camenisch, O. Distler, A. Ferenc, H. Cristina, H. E. Ryan, R. S. Johnson, K. F. Wagner, U. G. Stauffer, C. Bauer, M. Gassmann and M. Meuli: Physiologically low oxygen concentrations in fetal skin regulate hypoxia-inducible factor 1 and transforming growth factor-β3. Faseb J, 16(3), 411-3 (2002)
46. P. M. Villiger and M. Lotz: Differential expression of TGF β isoforms by human articular chondrocytes in response to growth factors. J Cell Physiol, 151(2), 318-25 (1992)
47. S. J. Kim, P. Angel, R. Lafyatis, K. Hattori, K. Y. Kim, M. B. Sporn, M. Karin and A. B. Roberts: Autoinduction of transforming growth factor β1 is mediated by the AP-1 complex. Mol Cell Biol, 10(4), 1492-7 (1990)
48. D. J. Grainger, C. D. Byrne, C. M. Witchell and J. C. Metcalfe: Transforming growth factor β is sequestered into an inactive pool by lipoproteins. J Lipid Res, 38(11), 2344- 52 (1997)
49. S. Hagiwara, Y. Murakumo, S. Mii, T. Shigetomi, N. Yamamoto, H. Furue, M. Ueda and M. Takahashi: Processing of CD109 by furin and its role in the regulation of TGF-β signaling. Oncogene, 29(15), 2181-91 (2010)
50. A. Hockla, D. C. Radisky and E. S. Radisky: Mesotrypsin promotes malignant growth of breast cancer cells through shedding of CD109. Breast Cancer Res Treat (2009)
51. C. Bernabeu, J. M. Lopez-Novoa and M. Quintanilla: The emerging role of TGF-β superfamily co-receptors in cancer. Biochim Biophys Acta, 1792(10), 954-73 (2009)
52. M. Hasegawa, S. Moritani, Y. Murakumo, T. Sato, S. Hagiwara, C. Suzuki, S. Mii, M. Jijiwa, A. Enomoto, N. Asai, S. Ichihara and M. Takahashi: CD109 expression in basal-like breast carcinoma. Pathol Int, 58(5), 288-94 (2008)
53. E. Pardali and P. ten Dijke: Transforming growth factor-β signaling and tumor angiogenesis. Front Biosci, 14, 4848-61 (2009)
54. P. ten Dijke, M. J. Goumans and E. Pardali: Endoglin in angiogenesis and vascular diseases. Angiogenesis, 11(1), 79-89 (2008)
55. C. E. Gatza, S. Y. Oh and G. C. Blobe: Roles for the type III TGF-β receptor in human cancer. Cell Signal, 22(8), 1163-74 (2010)
56. S. McLean and G. M. Di Guglielmo: TβRIII directs clathrin-mediated endocytosis of TGFβ type I and II receptors. Biochem J, 429(1), 137-145 (2010)
57. E. C. Finger, N. Y. Lee, H. J. You and G. C. Blobe: Endocytosis of the type III TGF-β receptor through the clathrin-independent/lipid raft pathway regulates TGF-β signaling and receptor downregulation. J Biol Chem, 283(50), 34808-18 (2008)
58. C. Santander and E. Brandan: Betaglycan induces TGF- β signaling in a ligand-independent manner, through activation of the p38 pathway. Cell Signal, 18(9), 1482-91 (2006)
59. H. J. You, M. W. Bruinsma, T. How, J. H. Ostrander and G. C. Blobe: The type III TGF-β receptor signals through both Smad3 and the p38 MAP kinase pathways to contribute to inhibition of cell proliferation. Carcinogenesis, 28(12), 2491-2500 (2007)
60. W. Chen, K. C. Kirkbride, T. How, C. D. Nelson, J. Mo, J. P. Frederick, X. F. Wang, R. J. Lefkowitz and G. C. Blobe: β-arrestin 2 mediates endocytosis of type III TGF-β receptor and down-regulation of its signaling. Science, 301(5638), 1394-7 (2003)
61. K. R. Solomon, P. Sharma, M. Chan, P. T. Morrison and R. W. Finberg: CD109 represents a novel branch of the a2-macroglobulin/complement gene family. Gene, 327(2), 171-183 (2004)
62. M. Hashimoto, M. Ichihara, T. Watanabe, K. Kawai, K. Koshikawa, N. Yuasa, T. Takahashi, Y. Yatabe, Y. Murakumo, J.-m. Zhang, Y. Nimura and M. Takahashi: Expression of CD109 in human cancer. Oncogene, 23(20), 3716-3720 (2004)
63. A. C. Schuh, N. A. Watkins, Q. Nguyen, N. J. Harmer, M. Lin, J. Y. A. Prosper, K. Campbell, D. R. Sutherland, P. Metcalfe, W. Horsfall and W. H. Ouwehand: A tyrosine703serine polymorphism of CD109 defines the Gov platelet alloantigens. Blood, 99(5), 1692-1698 (2002)
64. M. Lin, D. R. Sutherland, W. Horsfall, N. Totty, E. Yeo, R. Nayar, X.-F. Wu and A. C. Schuh: Cell surface antigen CD109 is a novel member of the alpha 2 macroglobulin/C3, C4, C5 family of thioester-containing proteins. Blood, 99(5), 1683-1691 (2002)
65. K. W. Finnson, B. Y. Tam, K. Liu, A. Marcoux, P. Lepage, S. Roy, A. A. Bizet and A. Philip: Identification of CD109 as part of the TGF-β receptor system in human keratinocytes. Faseb J, 20(9), 1525-7 (2006)
66. A. Bizet, K. Liu, N. Tran-Khanh, A. Saksena, J. Vorstenbosch, K. Finnson, M. Buschmann and A. Philip: The TGF-β co-receptor, CD109, promotes internalization and degradation of TGF-β receptors. BBA-Molecular Cell Research: accepted for publication (2010)
67. Y. Ohshima, I. Yajima, M. Y. Kumasaka, T. Yanagishita, D. Watanabe, M. Takahashi, Y. Inoue, H. Ihn, Y. Matsumoto and M. Kato: CD109 expression levels in malignant melanoma. J Dermatol Sci (2009)
68. S. Hagiwara, Y. Murakumo, T. Sato, T. Shigetom, K. Mitsudo, I. Tohnai, M. Ueda and M. Takahashi: Upregulation of CD109 expression is associated with carcinogenesis of the squamous epithelium of the oral cavity. Cancer Science, 99(10), 1916-1923 (2008)
69. T. Sato, Y. Murakumo, S. Hagiwara, M. Jijiwa, C. Suzuki, Y. Yatabe and M. Takahashi: High-level expression of CD109 is frequently detected in lung squamous cell carcinomas. Pathology International, 57, 719-724 (2007)
70. J. M. Zhang, M. Hashimoto, K. Kawai, Y. Murakumo, T. Sato, M. Ichihara, S. Nakamura and M. Takahashi: CD109 expression in squamous cell carcinoma of the uterine cervix. Pathol Int, 55(4), 165-9 (2005)
71. K. H. Wrighton, X. Lin and X. H. Feng: Phosphocontrol of TGF-β superfamily signaling. Cell Res, 19(1), 8- 20 (2009)
72. X. Yan, Z. Liu and Y. Chen: Regulation of TGF-β signaling by Smad7. Acta Biochim Biophys Sin (Shanghai), 41(4), 263-72 (2009)
73. Y. Inoue and T. Imamura: Regulation of TGF-β family signaling by E3 ubiquitin ligases. Cancer Sci (2008)
74. G. Valdimarsdottir, M. J. Goumans, F. Itoh, S. Itoh, C. H. Heldin and P. ten Dijke: Smad7 and protein phosphatase 1a are critical determinants in the duration of TGF- β/ALK1 signaling in endothelial cells. BMC Cell Biol, 7, 16 (2006)
75. A. M. Bhosale and J. B. Richardson: Articular cartilage: structure, injuries and review of management. Br Med Bull, 87, 77-95 (2008)
76. D. R. Eyre: Collagens and cartilage matrix homeostasis. Clin Orthop Relat Res(427 Suppl), S118-22 (2004)
77. D. R. Eyre, M. A. Weis and J. J. Wu: Articular cartilage collagen: an irreplaceable framework? Eur Cell Mater, 12, 57-63 (2006)
78. D. Heinegard: Proteoglycans and more - from molecules to biology. Int J Exp Pathol, 90(6), 575-86 (2009)
79. M. B. Goldring, K. Tsuchimochi and K. Ijiri: The control of chondrogenesis. J Cell Biochem, 97(1), 33-44 (2006)
80. I. Onyekwelu, M. B. Goldring and C. Hidaka: Chondrogenesis, joint formation, and articular cartilage regeneration. J Cell Biochem, 107(3), 383-92 (2009)
81. Y. Kawakami, J. Rodriguez-Leon and J. C. Izpisua Belmonte: The role of TGF-βs and Sox9 during limb chondrogenesis. Curr Opin Cell Biol, 18(6), 723-9 (2006)
82. L. Quintana, N. I. zur Nieden and C. E. Semino: Morphogenetic and regulatory mechanisms during developmental chondrogenesis: new paradigms for cartilage tissue engineering. Tissue Eng Part B Rev, 15(1), 29-41 (2009)
83. X. Yang, L. Chen, X. Xu, C. Li, C. Huang and C.-X. Deng: TGF-β/Smad3 signals repress chondrocyte hypertrophic differentiation and are required for maintaining articular cartilage. J. Cell Biol., 153(1), 35-46 (2001)
84. E. M. Darling and K. A. Athanasiou: Articular cartilage bioreactors and bioprocesses. Tissue Eng, 9(1), 9-26 (2003)
85. B. Vanwanseele, F. Eckstein, H. Knecht, E. Stussi and A. Spaepen: Knee cartilage of spinal cord-injured patients displays progressive thinning in the absence of normal joint loading and movement. Arthritis Rheum, 46(8), 2073-8 (2002)
86. S. B. Abramson and M. Attur: Developments in the scientific understanding of osteoarthritis. Arthritis Res Ther, 11(3), 227 (2009)
87. M. A. Adams, P. Dolan and D. S. McNally: The internal mechanical functioning of intervertebral discs and articular cartilage, and its relevance to matrix biology. Matrix Biol, 28(7), 384-9 (2009)
88. P. Malaviya and R. M. Nerem: Fluid-induced shear stress stimulates chondrocyte proliferation partially mediated via TGF-β1. Tissue Eng, 8(4), 581-90 (2002)
89. C. P. Neu, A. Khalafi, K. Komvopoulos, T. M. Schmid and A. H. Reddi: Mechanotransduction of bovine articular cartilage superficial zone protein by transforming growth factor β signaling. Arthritis Rheum, 56(11), 3706-14 (2007)
90. E. J. Koay, G. Ofek and K. A. Athanasiou: Effects of TGF-β1 and IGF-I on the compressibility, biomechanics, and strain-dependent recovery behavior of single chondrocytes. J Biomech, 41(5), 1044-52 (2008)
91. G. DuRaine, C. P. Neu, S. M. Chan, K. Komvopoulos, R. K. June and A. H. Reddi: Regulation of the friction coefficient of articular cartilage by TGF-β1 and IL-1β. J Orthop Res, 27(2), 249-56 (2009)
92. R. L. Mauck, S. B. Nicoll, S. L. Seyhan, G. A. Ateshian and C. T. Hung: Synergistic action of growth factors and dynamic loading for articular cartilage tissue engineering. Tissue Eng, 9(4), 597-611 (2003)
93. E. G. Lima, L. Bian, K. W. Ng, R. L. Mauck, B. A. Byers, R. S. Tuan, G. A. Ateshian and C. T. Hung: The beneficial effect of delayed compressive loading on tissueengineered cartilage constructs cultured with TGF-β3. Osteoarthritis Cartilage, 15(9), 1025-33 (2007)
94. E. G. Lima, L. Bian, R. L. Mauck, B. A. Byers, R. S. Tuan, G. A. Ateshian and C. T. Hung: The effect of applied compressive loading on tissue-engineered cartilage constructs cultured with TGF-β3. Conf Proc IEEE Eng Med Biol Soc, 1, 779-82 (2006)
95. J. Chimal-Monroy and L. Diaz de Leon: Differential effects of transforming growth factors β1, β2, β3 and β5 on chondrogenesis in mouse limb bud mesenchymal cells. Int J Dev Biol, 41(1), 91-102 (1997)
96. M. E. Joyce, A. B. Roberts, M. B. Sporn and M. E. Bolander: Transforming growth factor-β and the initiation of chondrogenesis and osteogenesis in the rat femur. J Cell Biol, 110(6), 2195-207 (1990)
97. H. L. Glansbeek, H. M. van Beuningen, E. L. Vitters, P. M. van der Kraan and W. B. van den Berg: Stimulation of articular cartilage repair in established arthritis by local administration of transforming growth factor-β into murine knee joints. Lab Invest, 78(2), 133-42 (1998)
98. E. B. Hunziker: Growth-factor-induced healing of partial-thickness defects in adult articular cartilage. Osteoarthritis Cartilage, 9(1), 22-32 (2001)
99. E. B. Hunziker and L. C. Rosenberg: Repair of partialthickness defects in articular cartilage: cell recruitment from the synovial membrane. J Bone Joint Surg Am, 78(5), 721-33 (1996)
100. A. Scharstuhl, H. L. Glansbeek, H. M. van Beuningen, E. L. Vitters, P. M. van der Kraan and W. B. van den Berg: Inhibition of endogenous TGF-β during experimental osteoarthritis prevents osteophyte formation and impairs cartilage repair. J Immunol, 169(1), 507-514 (2002)
101. R. Serra, M. Johnson, E. H. Filvaroff, J. LaBorde, D. M. Sheehan, R. Derynck and H. L. Moses: Expression of a truncated, kinase-defective TGF-β type II receptor in mouse skeletal tissue promotes terminal chondrocyte differentiation and osteoarthritis. J. Cell Biol., 139(2), 541- 552 (1997)
102. T. F. Li, M. Darowish, M. J. Zuscik, D. Chen, E. M. Schwarz, R. N. Rosier, H. Drissi and R. J. O'Keefe: Smad3- deficient chondrocytes have enhanced BMP signaling and accelerated differentiation. J Bone Miner Res, 21(1), 4-16 (2006)
103. E. N. Blaney Davidson, E. L. Vitters, P. M. van der Kraan and W. B. van den Berg: Expression of transforming growth factor-β (TGFβ) and the TGFβ signalling molecule Smad-2P in spontaneous and instability-induced osteoarthritis: role in cartilage degradation, chondrogenesis and osteophyte formation. Ann Rheum Dis, 65(11), 1414- 1421 (2006)
104. J. Loughlin: The genetic epidemiology of human primary osteoarthritis: current status. Expert Rev Mol Med, 7(9), 1-12 (2005)
105. S. Ikegawa: New gene associations in osteoarthritis: what do they provide, and where are we going? Curr Opin Rheumatol, 19(5), 429-34 (2007)
106. S. Ikegawa: Expression, regulation and function of asporin, a susceptibility gene in common bone and joint diseases. Curr Med Chem, 15(7), 724-8 (2008)
107. J. Dai and S. Ikegawa: Recent advances in association studies of osteoarthritis susceptibility genes. J Hum Genet, 55(2), 77-80 (2010)
108. H. M. van Beuningen, P. M. van der Kraan, O. J. Arntz and W. B. van den Berg: Transforming growth factor-β1 stimulates articular chondrocyte proteoglycan synthesis and induces osteophyte formation in the murine knee joint. Lab Invest, 71(2), 279-90 (1994)
109. H. M. van Beuningen, H. L. Glansbeek, P. M. van der Kraan and W. B. van den Berg: Osteoarthritis-like changes in the murine knee joint resulting from intra-articular transforming growth factor-β injections. Osteoarthritis Cartilage, 8(1), 25-33 (2000)
110. A. C. Bakker, F. A. van de Loo, H. M. van Beuningen, P. Sime, P. L. van Lent, P. M. van der Kraan, C. D. Richards and W. B. van den Berg: Overexpression of active TGF-β1 in the murine knee joint: evidence for synoviallayer- dependent chondro-osteophyte formation. Osteoarthritis Cartilage, 9(2), 128-36 (2001)
111. M. J. Alcaraz, J. Megias, I. Garcia-Arnandis, V. Clerigues and M. I. Guillen: New molecular targets for the treatment of osteoarthritis. Biochem Pharmacol, 80(1), 13- 21 (2010)
112. M. B. Goldring and S. R. Goldring: Articular cartilage and subchondral bone in the pathogenesis of osteoarthritis. Ann N Y Acad Sci, 1192(1), 230-7 (2010)
113. A. Shane Anderson and R. F. Loeser: Why is osteoarthritis an age-related disease? Best Pract Res Clin Rheumatol, 24(1), 15-26 (2010)
114. J. Martel-Pelletier and J. P. Pelletier: Is osteoarthritis a disease involving only cartilage or other articular tissues? Eklem Hastalik Cerrahisi, 21(1), 2-14 (2010)
115. H. B. Sun: Mechanical loading, cartilage degradation, and arthritis. Ann N Y Acad Sci, 1211(1), 37-50 (2010)
116. S. R. Goldring and M. B. Goldring: Bone and cartilage in osteoarthritis: is what's best for one good or bad for the other? Arthritis Res Ther, 12(5), 143 (2010)
117. Y. Henrotin, L. Pesesse and C. Sanchez: Subchondral bone in osteoarthritis physiopathology: state-of-the art and perspectives. Biomed Mater Eng, 19(4-5), 311-6 (2009)
118. J. Wu, W. Liu, A. Bemis, E. Wang, Y. Qiu, E. A. Morris, C. R. Flannery and Z. Yang: Comparative proteomic characterization of articular cartilage tissue from normal donors and patients with osteoarthritis. Arthritis Rheum, 56(11), 3675-84 (2007)
119. M. P. Verdier, S. Seite, K. Guntzer, J. P. Pujol and K. Boumediene: Immunohistochemical analysis of transforming growth factor β isoforms and their receptors in human cartilage from normal and osteoarthritic femoral heads. Rheumatol Int, 25(2), 118-24 (2005)
120. K. Boumediene, T. Conrozier, P. Mathieu, M. Richard, C. Marcelli, E. Vignon and J. P. Pujol: Decrease of cartilage transforming growth factor-β receptor II expression in the rabbit experimental osteoarthritispotential role in cartilage breakdown. Osteoarthritis Cartilage, 6(2), 146-9 (1998)
121. J. Xiao, T. Li, Z. Wu, Z. Shi, J. Chen, S. K. Lam, Z. Zhao, L. Yang and G. Qiu: REST corepressor (CoREST) repression induces phenotypic gene regulation in advanced osteoarthritic chondrocytes. J Orthop Res, 28(12), 1569-75 (2010)
122. M. Pombo-Suarez, M. T. Castano-Oreja, M. Calaza, J. J. Gomez-Reino and A. Gonzalez: Differential upregulation of the three TGF-β isoforms in human osteoarthritic cartilage. Ann Rheum Dis, 68(4), 568-71 (2009)
123. M. Nakajima, H. Kizawa, M. Saitoh, I. Kou, K. Miyazono and S. Ikegawa: Mechanisms for asporin function and regulation in articular cartilage. J. Biol. Chem., 282(44), 32185-92 (2007)
124. C. T. Appleton, V. Pitelka, J. Henry and F. Beier: Global analyses of gene expression in early experimental osteoarthritis. Arthritis Rheum, 56(6), 1854-68 (2007)
125. J. P. Pujol, C. Chadjichristos, F. Legendre, C. Bauge, G. Beauchef, R. Andriamanalijaona, P. Galera and K. Boumediene: Interleukin-1 and transforming growth factor- β1 as crucial factors in osteoarthritic cartilage metabolism. Connect Tissue Res, 49(3), 293-7 (2008)
126. T. Wei, N. H. Kulkarni, Q. Q. Zeng, L. M. Helvering, X. Lin, F. Lawrence, L. Hale, M. G. Chambers, C. Lin, A. Harvey, Y. L. Ma, R. L. Cain, J. Oskins, M. A. Carozza, D. D. Edmondson, T. Hu, R. R. Miles, T. P. Ryan, J. E. Onyia and P. G. Mitchell: Analysis of early changes in the articular cartilage transcriptisome in the rat meniscal tear model of osteoarthritis: pathway comparisons with the rat anterior cruciate transection model and with human osteoarthritic cartilage. Osteoarthritis Cartilage, 18(7), 992-1000 (2010)
127. T. Aigner, K. Fundel, J. Saas, P. M. Gebhard, J. Haag, T. Weiss, A. Zien, F. Obermayr, R. Zimmer and E. Bartnik: Large-scale gene expression profiling reveals major pathogenetic pathways of cartilage degeneration in osteoarthritis. Arthritis Rheum, 54(11), 3533-44 (2006)
128. B. Dabovic, Y. Chen, C. Colarossi, H. Obata, L. Zambuto, M. A. Perle and D. B. Rifkin: Bone abnormalities in latent TGF-β binding protein (LTBP)- 3-null mice indicate a role for LTBP-3 in modulating TGF-β bioavailability. J Cell Biol, 156(2), 227-32 (2002)
129. B. Dabovic, Y. Chen, C. Colarossi, L. Zambuto, H. Obata and D. B. Rifkin: Bone defects in latent TGF-β binding protein (LTBP)-3 null mice; a role for LTBP in TGF-β presentation. J Endocrinol, 175(1), 129-41 (2002)
130. K. Johnson, S. Hashimoto, M. Lotz, K. Pritzker and R. Terkeltaub: Interleukin-1 induces pro-mineralizing activity of cartilage tissue transglutaminase and factor XIIIa. Am J Pathol, 159(1), 149-63 (2001)
131. D. Heinkel, C. M. Gohr, M. Uzuki and A. K. Rosenthal: Transglutaminase contributes to CPPD crystal formation in osteoarthritis. Front Biosci, 9, 3257-61 (2004)
132. A. Orlandi, F. Oliva, G. Taurisano, E. Candi, A. Di Lascio, G. Melino, L. G. Spagnoli and U. Tarantino: Transglutaminase-2 differently regulates cartilage destruction and osteophyte formation in a surgical model of osteoarthritis. Amino Acids, 36(4), 755-63 (2009)
133. J. L. Huebner, K. A. Johnson, V. B. Kraus and R. A. Terkeltaub: Transglutaminase 2 is a marker of chondrocyte hypertrophy and osteoarthritis severity in the Hartley guinea pig model of knee OA. Osteoarthritis Cartilage, 17(8), 1056-64 (2009)
134. D. Pfander, T. Cramer, D. Deuerling, G. Weseloh and B. Swoboda: Expression of thrombospondin-1 and its receptor CD36 in human osteoarthritic cartilage. Ann Rheum Dis, 59(6), 448-54 (2000)
135. M. G. Attur, G. D. Palmer, H. E. Al-Mussawir, M. Dave, C. C. Teixeira, D. B. Rifkin, C. T. Appleton, F. Beier and S. B. Abramson: F-spondin, a neuroregulatory protein, is up-regulated in osteoarthritis and regulates cartilage metabolism via TGF-β activation. Faseb J, 23(1), 79-89 (2009)
136. C. Karlsson, T. Dehne, A. Lindahl, M. Brittberg, A. Pruss, M. Sittinger and J. Ringe: Genome-wide expression profiling reveals new candidate genes associated with osteoarthritis. Osteoarthritis Cartilage, 18(4), 581-92 (2010)
137. I. M. Jou, A. L. Shiau, S. Y. Chen, C. R. Wang, D. B. Shieh, C. S. Tsai and C. L. Wu: Thrombospondin 1 as an effective gene therapeutic strategy in collagen-induced arthritis. Arthritis Rheum, 52(1), 339-44 (2005)
138. J. L. Hsieh, P. C. Shen, A. L. Shiau, I. M. Jou, C. H. Lee, C. R. Wang, M. L. Teo and C. L. Wu: Intra-articular gene transfer of thrombospondin-1 suppresses the disease progression of experimental osteoarthritis. J Orthop Res (2010)
139. M. H. Barcellos-Hoff and T. A. Dix: Redox-mediated activation of latent transforming growth factor-β1. Mol Endocrinol, 10(9), 1077-83 (1996)
140. V. B. Kraus, J. L. Huebner, T. Stabler, C. M. Flahiff, L. A. Setton, C. Fink, V. Vilim and A. G. Clark: Ascorbic acid increases the severity of spontaneous knee osteoarthritis in a guinea pig model. Arthritis Rheum, 50(6), 1822-31 (2004)
141. T. Hayami, M. Pickarski, G. A. Wesolowski, J. McLane, A. Bone, J. Destefano, G. A. Rodan and T. Duong le: The role of subchondral bone remodeling in osteoarthritis: reduction of cartilage degeneration and prevention of osteophyte formation by alendronate in the rat anterior cruciate ligament transection model. Arthritis Rheum, 50(4), 1193-206 (2004)
142. T. Dehne, C. Karlsson, J. Ringe, M. Sittinger and A. Lindahl: Chondrogenic differentiation potential of osteoarthritic chondrocytes and their possible use in matrixassociated autologous chondrocyte transplantation. Arthritis Res Ther, 11(5), R133 (2009)
143. E. N. Blaney Davidson, D. F. Remst, E. L. Vitters, H. M. van Beuningen, A. B. Blom, M. J. Goumans, W. B. van den Berg and P. M. van der Kraan: Increase in ALK1/ALK5 ratio as a cause for elevated MMP-13 expression in osteoarthritis in humans and mice. J Immunol, 182(12), 7937-45 (2009)
144. M. A. Gomez-Camarillo and J. B. Kouri: Ontogeny of rat chondrocyte proliferation: studies in embryo, adult and osteoarthritic (OA) cartilage. Cell Res, 15(2), 99-104 (2005)
145. E. N. Blaney Davidson, A. Scharstuhl, E. L. Vitters, P. M. van der Kraan and W. B. van den Berg: Reduced transforming growth factor-β signaling in cartilage of old mice: role in impaired repair capacity. Arthritis Res Ther, 7(6), R1338-47 (2005)
146. Q. Wu, J. H. Huang, E. R. Sampson, K. O. Kim, M. J. Zuscik, R. J. O'Keefe, D. Chen and R. N. Rosier: Smurf2 induces degradation of GSK-3β and upregulates β-catenin in chondrocytes: a potential mechanism for Smurf2-induced degeneration of articular cartilage. Exp Cell Res (2009)
147. C. G. Li, Q. Q. Liang, Q. Zhou, E. Menga, X. J. Cui, B. Shu, C. J. Zhou, Q. Shi and Y. J. Wang: A continuous observation of the degenerative process in the intervertebral disc of Smad3 gene knock-out mice. Spine (Phila Pa 1976), 34(13), 1363-9 (2009)
148. J. Y. Yao, Y. Wang, J. An, C. M. Mao, N. Hou, Y. X. Lv, Y. L. Wang, F. Cui, M. Huang and X. Yang: Mutation analysis of the Smad3 gene in human osteoarthritis. Eur J Hum Genet, 11(9), 714-7 (2003)
149. A. M. Valdes, T. D. Spector, A. Tamm, K. Kisand, S. A. Doherty, E. M. Dennison, M. Mangino, I. Kerna, D. J. Hart, M. Wheeler, C. Cooper, R. J. Lories, N. K. Arden and M. Doherty: Genetic variation in the Smad3 gene is associated with hip and knee osteoarthritis. Arthritis Rheum, 62(8), 2347-2352 (2010)
150. J. Pannu, S. Nakerakanti, E. Smith, P. t. Dijke and M. Trojanowska: Transforming growth factor-β receptor type I dependent fibrogenic gene program is mediated via activation of Smad1 and ERK1/2 pathways. J. Biol. Chem., 282(14), 10405-10413 (2007)
151. U. Valcourt, J. Gouttenoire, A. Moustakas, D. Herbage and F. Mallein-Gerin: Functions of transforming growth factor-β family type I receptors and Smad proteins in the hypertrophic maturation and osteoblastic differentiation of chondrocytes. J Biol Chem, 277(37), 33545-58 (2002)
152. B. Bau, J. Haag, E. Schmid, M. Kaiser, P. M. Gebhard and T. Aigner: Bone morphogenetic proteinmediating receptor-associated Smads as well as common Smad are expressed in human articular chondrocytes but not up-regulated or down-regulated in osteoarthritic cartilage. J Bone Miner Res, 17(12), 2141-50 (2002)
153. S. Otsuki, S. R. Hanson, S. Miyaki, S. P. Grogan, M. Kinoshita, H. Asahara, C. H. Wong and M. K. Lotz: Extracellular sulfatases support cartilage homeostasis by regulating BMP and FGF signaling pathways. Proc Natl Acad Sci U S A, 107(22), 10202-7 (2010)
154. S. Otsuki, N. Taniguchi, S. P. Grogan, D. D'Lima, M. Kinoshita and M. Lotz: Expression of novel extracellular sulfatases Sulf-1 and Sulf-2 in normal and osteoarthritic articular cartilage. Arthritis Res Ther, 10(3), R61 (2008)
155. M. Kaiser, J. Haag, S. Soder, B. Bau and T. Aigner: Bone morphogenetic protein and transforming growth factor beta inhibitory Smads 6 and 7 are expressed in human adult normal and osteoarthritic cartilage in vivo and are differentially regulated in vitro by interleukin-1β. Arthritis Rheum, 50(11), 3535-40 (2004)
156. C. Bauge, J. Attia, S. Leclercq, J. P. Pujol, P. Galera and K. Boumediene: Interleukin-1β up-regulation of Smad7 via NF-kappaB activation in human chondrocytes. Arthritis Rheum, 58(1), 221-6 (2008)
157. C. Bauge, F. Legendre, S. Leclercq, J. M. Elissalde, J. P. Pujol, P. Galera and K. Boumediene: Interleukin-1β impairment of transforming growth factor β1 signaling by down-regulation of transforming growth factor β receptor type II and up-regulation of Smad7 in human articular chondrocytes. Arthritis Rheum, 56(9), 3020-32 (2007)
158. J. A. Roman-Blas, D. G. Stokes and S. A. Jimenez: Modulation of TGF-β signaling by proinflammatory cytokines in articular chondrocytes. Osteoarthritis Cartilage, 15(12), 1367-77 (2007)
159. R. F. Loeser: Aging and osteoarthritis: the role of chondrocyte senescence and aging changes in the cartilage matrix. Osteoarthritis Cartilage, 17(8), 971-9 (2009)
160. Q. Wu, K. O. Kim, E. R. Sampson, D. Chen, H. Awad, T. O'Brien, J. E.
161. F. Beier and R. F. Loeser: Biology and pathology of Rho GTPase, PI-3 kinase-Akt, and MAP kinase signaling pathways in chondrocytes. J Cell Biochem, 110(3), 573-80 (2010)
162. L. M. Gunnell, J. H. Jonason, A. E. Loiselle, A. Kohn, E. M. Schwarz, M. J. Hilton and R. J. O'Keefe: TAK1 regulates cartilage and joint development via the MAPK and BMP signaling pathways. J Bone Miner Res, 25(8), 1784-97 (2010)
163. B. Qiao, S. R. Padilla and P. D. Benya: TGF-β activated kinase 1 (TAK1) mimics and mediates TGF-β-induced stimulation of type II collagen synthesis in chondrocytes independent of Col2a1 transcription and Smad3 signaling. J. Biol. Chem., 280(17), 17562-71 (2005)
164. A. M. Ionescu, E. M. Schwarz, M. J. Zuscik, H. Drissi, J. E. Puzas, R. N. Rosier and R. J. O'Keefe: ATF-2 cooperates with Smad3 to mediate TGF-β effects on chondrocyte maturation. Exp Cell Res, 288(1), 198-207 (2003)
165. A. Leask: Targeting the TGFβ, endothelin-1 and CCN2 axis to combat fibrosis in scleroderma. Cell Signal, 20(8), 1409-14 (2008)
166. W. L. Parker, M. B. Goldring and A. Philip: Endoglin is expressed on human chondrocytes and forms a heteromeric complex with betaglycan in a ligand and type II TGFβ receptor independent manner. J Bone Miner Res, 18(2), 289-302 (2003)
167. K. W. Finnson, W. L. Parker, Y. Chi, C. Hoemann, M. B. Goldring, J. Antoniou and A. Philip: Endoglin differentially regulates TGF-β-induced Smad2/3 and Smad1/5 signalling and its expression correlates with extracellular matrix production and cellular differentiation state in human chondrocytes. Osteoarthritis Cartilage, 18(11), 1518-27 (2010)
168. S. Honsawek, A. Tanavalee and P. Yuktanandana: Elevated circulating and synovial fluid endoglin are associated with primary knee osteoarthritis severity. Arch Med Res, 40(7), 590-4 (2009)
169. K. Tsuritani, J. Takeda, J. Sakagami, A. Ishii, T. Eriksson, T. Hara, H. Ishibashi, Y. Koshihara, K. Yamada and Y. Yoneda: Cytokine receptor-like factor 1 is highly expressed in damaged human knee osteoarthritic cartilage and involved in osteoarthritis downstream of TGF-β. Calcif Tissue Int, 86(1), 47-57 (2010)
170. F. Dell'accio, C. De Bari, N. M. Eltawil, P. Vanhummelen and C. Pitzalis: Identification of the molecular response of articular cartilage to injury, by microarray screening: Wnt-16 expression and signaling after injury and in osteoarthritis. Arthritis Rheum, 58(5), 1410-21 (2008)
171. R. Rollin, R. Alvarez-Lafuente, F. Marco, J. A. Garcia-Asenjo, J. A. Jover, L. Rodriguez, L. Lopez-Duran and B. Fernandez-Gutierrez: Abnormal transforming growth factor-β expression in mesenchymal stem cells from patients with osteoarthritis. J Rheumatol (2008)
172. E. Sanchez-Sabate, L. Alvarez, E. Gil-Garay, L. Munuera and N. Vilaboa: Identification of differentially expressed genes in trabecular bone from the iliac crest of osteoarthritic patients. Osteoarthritis Cartilage, 17(8), 1106-14 (2009)
173. A. Bizet, K. Liu, N. Tran-Khanh, A. Saksena, K. Finnson, M. Buschmann and A. Philip: CD109, a TGF-β coreceptor, regulates TGF-β receptor internalization and degradation in keratinocytes. In: 16th Annual Meeting of the Society for Investigative Dermatology. Ed P. Bergstresser. The Journal of Investigative Dermatology, Nature Publishing Group, Montreal, QC, Canada (2009)
174. M. Polacek, J. A. Bruun, O. Johansen and I. Martinez: Differences in the secretome of cartilage explants and cultured chondrocytes unveiled by SILAC technology. J Orthop Res, 28(8), 1040-1049 (2010)
175. A. L. Stevens, J. S. Wishnok, D. H. Chai, A. J. Grodzinsky and S. R. Tannenbaum: A sodium dodecyl sulfate-polyacrylamide gel electrophoresis-liquid chromatography tandem mass spectrometry analysis of bovine cartilage tissue response to mechanical compression injury and the inflammatory cytokines tumor necrosis factor-a and interleukin-1β. Arthritis Rheum, 58(2), 489- 500 (2008)
176. P. K. Dagur, G. Tatlici, M. Gourley, L. Samsel, N. Raghavachari, P. Liu, D. Liu and J. P. McCoy, Jr.: CD146+ T lymphocytes are increased in both the peripheral circulation and in the synovial effusions of patients with various musculoskeletal diseases and display proinflammatory gene profiles. Cytometry B Clin Cytom, 78B, 88-95 (2010)
177. A. Yoshimura, Y. Wakabayashi and T. Mori: Cellular and molecular basis for the regulation of inflammation by TGF-β. J Biochem (2010)
178. X. H. Feng and R. Derynck: Specificity and versatility in TGF-β signaling through Smads. Annu Rev Cell Dev Biol, 21, 659-93 (2005)
179. C. Man, S. Zhu, B. Zhang and J. Hu: Protection of articular cartilage from degeneration by injection of transforming growth factor-β in temporomandibular joint osteoarthritis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 108(3), 335-40 (2009)
180. H. M. van Beuningen, P. M. van der Kraan, O. J. Arntz and W. B. van den Berg: In vivo protection against interleukin-1-induced articular cartilage damage by transforming growth factor-β1: age-related differences. Ann Rheum Dis, 53(9), 593-600 (1994)
181. H. M. van Beuningen, P. M. van der Kraan, O. J. Arntz and W. B. van den Berg: Protection from interleukin 1 induced destruction of articular cartilage by transforming growth factor β: studies in anatomically intact cartilage in vitro and in vivo. Ann Rheum Dis, 52(3), 185-91 (1993)
182. A. Scharstuhl, E. L. Vitters, P. M. van der Kraan and W. B. van den Berg: Reduction of osteophyte formation and synovial thickening by adenoviral overexpression of transforming growth factor β/bone morphogenetic protein inhibitors during experimental osteoarthritis. Arthritis Rheum, 48(12), 3442-51 (2003)
183. E. N. Blaney Davidson, E. L. Vitters, W. B. van den Berg and P. M. van der Kraan: TGFβ-induced cartilage repair is maintained but fibrosis is blocked in the presence of Smad7. Arthritis Res Ther, 8(3), R65 (2006)
184. M. M. Vilchis-Landeros, J. L. Montiel, V. Mendoza, G. Mendoza-Hernandez and F. Lopez-Casillas: Recombinant soluble betaglycan is a potent and isoformselective transforming growth factor-β neutralizing agent. Biochem J, 355(Pt 1), 215-22 (2001)
185. S. Venkatesha, M. Toporsian, C. Lam, J. Hanai, T. Mammoto, Y. M. Kim, Y. Bdolah, K. H. Lim, H. T. Yuan, T. A. Libermann, I. E. Stillman, D. Roberts, P. A. D'Amore, F. H. Epstein, F. W. Sellke, R. Romero, V. P. Sukhatme, M. Letarte and S. A. Karumanchi: Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med, 12(6), 642-9 (2006)
186. B. Tam, D. Larouche, L. Germain, N. Hooper and A. Philip: Characterization of a 150 kDa accessory receptor for TGF-β1 on keratinocytes: direct evidence for a GPI anchor and ligand binding of the released form. Journal of Cellular Biochemistry, 83, 494-507 (2001)
187. T. Schubert, S. Kaufmann, A. K. Wenke, S. Grassel and A. K. Bosserhoff: Role of deleted in colon carcinoma in osteoarthritis and in chondrocyte migration. Rheumatology (Oxford), 48(11), 1435-41 (2009)
188. C. L. Murphy: HIF-2a - a mediator of osteoarthritis? Cell Res, 20(9), 977-9 (2010)
189. T. Saito, A. Fukai, A. Mabuchi, T. Ikeda, F. Yano, S. Ohba, N. Nishida, T. Akune, N. Yoshimura, T. Nakagawa, K. Nakamura, K. Tokunaga, U. I. Chung and H. Kawaguchi: Transcriptional regulation of endochondral ossification by HIF-2a during skeletal growth and osteoarthritis development. Nat Med, 16(6), 678-86 (2010)
190. B. L. Thoms and C. L. Murphy: Inhibition of hypoxiainducible factor-targeting prolyl hydroxylase domaincontaining protein 2 (PHD2) enhances matrix synthesis by human chondrocytes. J Biol Chem, 285(27), 20472-80 (2010)
191. S. Yang, J. Kim, J. H. Ryu, H. Oh, C. H. Chun, B. J. Kim, B. H. Min and J. S. Chun: Hypoxia-inducible factor- 2a is a catabolic regulator of osteoarthritic cartilage destruction. Nat Med, 16(6), 687-93 (2010)
192. P. M. van der Kraan, E. N. Blaney Davidson and W. B. van den Berg: Bone morphogenetic proteins and articular cartilage: To serve and protect or a wolf in sheep clothing's? Osteoarthritis Cartilage, 18(6), 735-41 (2010)
193. Z. Zhou, J. Xie, D. Lee, Y. Liu, J. Jung, L. Zhou, S. Xiong, L. Mei and W. C. Xiong: Neogenin regulation of BMP-induced canonical Smad signaling and endochondral bone formation. Dev Cell, 19(1), 90-102 (2010)